logo
Select company
Select metric
$ -395KCapital Expenditure
VS
Market
97
Sector
98
Industry
97
History
100
$ 9.88Close
$ 5.97 - $ 67 52-Week Range
Ticker Information

Ticker

MRSN

Company Name

MERSANA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MERSANA THERAPEUTICS INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRSN - CapEx Historical data
DateCapital Expenditure
6/30/2025$ -395K
3/31/2025$ 0
12/31/2024$ 132K
9/30/2024$ 518K
6/30/2024$ 990K
3/31/2024$ 1.39M
12/31/2023$ 2.17M
9/30/2023$ 2.57M
6/30/2023$ 2.52M
3/31/2023$ 2.78M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MERSANA THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx stands at $ 285K.
  • Over the past 5 years, MERSANA THERAPEUTICS INC's average CapEx has been $ 1.1M.
  • The median CapEx for MERSANA THERAPEUTICS INC during this period was $ 846.5K
  • MERSANA THERAPEUTICS INC reached its highest CapEx over the past 5 years at $ 2.78M.
  • The lowest CapEx recorded by MERSANA THERAPEUTICS INC in the same timeframe $ -395K

MERSANA THERAPEUTICS INC's CapEx vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Benchmarks
CompanyCapEx
XFOR : X4 PHARMACEUTICALS INC $ 3.13MGBIO : GENERATION BIO CO $ 848KXLO : XILIO THERAPEUTICS INC $ 438KSNYR : SYNERGY CHC CORP $ 0CCEL : CRYO CELL INTERNATIONAL INC $ 56.6KICCC : IMMUCELL CORP $ 739.61KCAMP : CAMP4 THERAPEUTICS CORP $ 542KIGC : IGC PHARMA INC $ -660KDYAI : DYADIC INTERNATIONAL INC $ 0RVP : RETRACTABLE TECHNOLOGIES INC $ 1.51M

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

MRSN - Capital Expenditure, Last 5 years

$ -395K

Minimum

Jun 30, 2025

$ 2.78M

Maximum

Mar 31, 2023

$ 1.1M

Average

$ 846.5K

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.66M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.66M
median$ 1.92M
std$ 15.86M